COX-2 inhibition is neither necessary nor sufficient for celecoxib to suppress tumor cell proliferation and focus formation in vitro
<p>Abstract</p> <p>Background</p> <p>An increasing number of reports is challenging the notion that the antitumor potential of the selective COX-2 inhibitor celecoxib (Celebrex<sup>®</sup>) is mediated primarily via the inhibition of COX-2. We have investiga...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2008-05-01
|
| Series: | Molecular Cancer |
| Online Access: | http://www.molecular-cancer.com/content/7/1/38 |